Advisornet Financial’s Lakefront Biotherapeutics American Depositary Shares LKFT Stock Holding History

Advisornet Financial’s Portfolio LKFT Stock Details LKFT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q3	–	Sell	-54	Closed	-$3K	–	1922
2022 Q2	$3K	Hold	54	–	–	﹤0.01%	1611
2022 Q1	$3K	Buy	+54	New	+$3.31K	﹤0.01%	1720
2020 Q2	–	Sell	-5	Closed	-$1K	–	1826
2020 Q1	$1K	Hold	5	–	–	﹤0.01%	1667
2019 Q4	$1K	Buy	+5	New	+$924	﹤0.01%	1746

Other funds holding LKFT

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

EcoR1 Capital San Francisco, California $2.36B AUM 204.53% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Prosight Management Dallas, Texas $610M AUM 40.86% 1-Year Est. Return

Finepoint Capital Boston, Massachusetts $1.95B AUM 45.61% 1-Year Est. Return

DCM

Driehaus Capital Management Chicago, Illinois $13.6B AUM 173.98% 1-Year Est. Return

Hudson Bay Capital Management Stamford, Connecticut $29B AUM 30.2% 1-Year Est. Return

Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

GPP

Great Point Partners Greenwich, Connecticut $435M AUM 318.81% 1-Year Est. Return

Advisornet Financial's LKFT Position: Q3 2022 in Review

Advisornet Financial sold out of Lakefront Biotherapeutics American Depositary Shares (LKFT) in Q3 2022, closing a stake of 54 shares — an estimated $3K sold.

Advisornet Financial first reported a position in LKFT in Q4 2019 and held it in 4 quarters. The position peaked at $3K in Q2 2022. 84 funds tracked by Wall St. Rank hold LKFT as of Q3 2022.

Advisornet Financial reported no remaining Lakefront Biotherapeutics American Depositary Shares position as of Q3 2022 after selling out during the quarter.
Advisornet Financial sold 54 Lakefront Biotherapeutics American Depositary Shares shares in Q3 2022, an estimated $3K.
Advisornet Financial first reported a position in Lakefront Biotherapeutics American Depositary Shares in Q4 2019 and held it in 4 quarters.
Advisornet Financial's Lakefront Biotherapeutics American Depositary Shares position peaked at $3K in Q2 2022.
84 funds tracked by Wall St. Rank held Lakefront Biotherapeutics American Depositary Shares as of Q3 2022.

Based on Advisornet Financial's 13F filing for Q3 2022, filed 4 Oct 2022.